Skip to main content

Funded Grants

Filter by:
Clear Filters
Filter by:
Prateep Pakavathkumar , Centre Hospitalier de l’Université de Montréal × Clear Filters

1 results found

Pre-clinical drug discovery against hexanucleotide repeat-containing C9orf72 toxicity using Caenorhabditis elegans and patient-derived induced motor neurons

A few years ago, Dr. Parker and researchers in his lab genetically engineered worms that mimicked human ALS through motor neuron degeneration and paralysis.


Grant type
Capacity building grants
Area of Research
Neurodegeneration
Competition
ALS Canada - Brain Canada Trainee Program 2018
Province
Québec
Start Date
2018